Related Experiment Videos
Multiple persistent keratoacanthomas: treatment with oral etretinate
Journal of the American Academy of Dermatology
|June 1, 1984
Summary
Multiple keratoacanthomas (KAs) are rare and difficult to treat. Oral etretinate successfully treated two patients, suggesting oral retinoids are a valuable option for this condition.
Area of Science:
- Dermatology
- Oncology
Background:
- Ferguson-Smith type multiple keratoacanthomas (KAs) are rare and challenging to manage.
- Existing treatments for KAs are often unrewarding.
Observation:
- Two patients with multiple KAs of the Ferguson-Smith type were treated.
- Both patients showed successful outcomes with oral etretinate therapy.
Findings:
- Oral etretinate demonstrated efficacy in treating multiple KAs.
- This supports the inclusion of oral retinoids in the therapeutic approach for KAs.
Implications:
- Oral retinoids are recommended for severe or disabling cases of multiple KAs.
- This expands treatment options for a rare and difficult-to-treat condition.